Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p63 expression is associated with high histological grade, aberrant p53 expression and TP53 mutation in HER2-positive breast carcinoma.

Journal of clinical pathology - 1 Oct 2021

Guo Shuangping, Wang Yingmei, Rohr Joseph, Shang Li, Ma Jing

Abstract excerpt

AIM: p63, a member of the p53 family, is a myoepithelial cell marker usually expressed in metaplastic breast carcinoma and its expression suggests a myoepithelial phenotype. However, its expression and association with clinicopathological features of human epidermal growth factor receptor 2 (HER 2)-positive breast carcinoma is poorly investigated. MATERIALS AND METHODS: Sixty-seven patients with oestrogen...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Differentiation

Share to Databases, Factual

Share to Neoplasm Grading

Share to Receptor, ErbB-2

Share to Tumor Suppressor Protein p53

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 32873702
DOI: 10.1136/jclinpath-2020-206643

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p63 expression is associated with high histological grade, aberrant p53 expression and TP53 mutation in HER2-positive breast carcinoma.PMID 32873702Read ↗

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative.Semantic proximity Read ↗

Taking Advantage of Basic Research: p63 Is a Reliable Myoepithelial and Stem Cell MarkerSemantic proximity Read ↗

p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.Semantic proximity Read ↗

Immunohistochemical study of p53 and Ki67 in a group of patients with mammary carcinoma.Semantic proximity Read ↗

p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?Semantic proximity Read ↗

ΔNp63 regulates cell proliferation, differentiation, adhesion, and migration in the BL2 subtype of basal-like breast cancer.Semantic proximity Read ↗

Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis.Semantic proximity Read ↗

Relationship between p63 and p53 expression in Merkel cell carcinoma and corresponding abnormalities in TP63 and TP53: a study and a proposal.Semantic proximity Read ↗

p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.Semantic proximity Read ↗

p63 expression in normal, hyperplastic and malignant breast tissues.Semantic proximity Read ↗

Effect of p63 Expression on Survival in Oral Squamous Cell CarcinomaSemantic proximity Read ↗

Expression of p63 in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.